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Mucobilia is a rare condition characterized by the
accumulation of abundant mucus within the intra- or
extrahepatic biliary tree. A variety of hepatobiliary
and pancreatic neoplasms are mucin producing
and have been associated with the development of
mucobilia including biliary mucinosis, biliary papil-
lomatosis, mucin-producing cholangiocarcinoma
(MPCC), or cystic neoplasms of the pancreas or
biliary tree (cystadenoma or cystadenocarcinoma).
We report the case of 46 year-old male with a biliary
cystadenocarcinoma of the caudate lobe which re-
sulted in chronic biliary obstruction and relapsing
cholangitis. A review of the literature for both muco-
bilia and biliary cystadenocarcinoma is provided
along with a discussion addressing the clinical pre-
sentation, diagnosis, treatment, and prognosis for
this rare entity.
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INTRODUCTION
Mucobilia is a rare condition characterized by
the accumulation of abundant mucus within the
intra- or extrahepatic biliary tree. The mucus is
typically rich in albumin and electrolytes and if
treated by external biliary drainage may result
in significant electrolyte abnormalities. A variety
of hepatobiliary and pancreatic neoplasms are
mucin-producing and have been associated with
the development of mucobilia [1]. These neoplas-
tic processes include biliary mucinosis, biliary
papillomatosis, mucin-producing cholangiocar-
cinoma (MPCC), or cystic neoplasms of the
pancreas or biliary tree (cystadenoma or cystade-
nocarcinoma) [1-4]. Due to the variety of
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neoplastic processes that may result in this condi-
tion, the clinical spectrum and presentation of
patients with mucobilia is varied. This report
describes a middle-aged male who developed
mucobilia and biliary obstruction due to a biliary
cystadenocarcinoma of the caudate duct.
CASE REPORT
The patient is a 46 year-old white male who was
referred for evaluation of a multiloculated cystic
lesion arising from the caudate lobe of the liver.
For five years, he reported bi-monthly fevers,
rigors, and intermittent episodes of jaundice that
occurred with increasing frequency in the last
three months. Prior ultrasound examinations
failed to reveal evidence of gallbladder disease,
choledocholithiasis or other liver pathology. The
patient was born in the United States with no
history of foreign travel. Amoebic and hepatitis
serologic tests were negative. Prior to referral,
his symptoms had been managed with chronic
antibiotic therapy for over two years. Three
months earlier, he was hospitalized with jaun-
dice, rigors and fever (40.2 C). Computed tomo-
graphy (CT) revealed a complex cystic mass in
the caudate lobe that was believed to be a
pyogenic hepatic abscess. Percutaneous aspira-
tion revealed clear viscous fluid and cytologic
analysis showed no malignant cells. Cultures
grew both Enterobacter cloacae and Enterococcus
faecalis. After two weeks of antibiotic therapy,
his fever persisted and a laparotomy was per-
formed. The cystic lesion was unroofed, and a
copious amount of clear mucus abd particulate
material was evacuated from the cyst cavity. His-
tologic review revealed a papillary cystadenoma
of biliary origin. Post-operatively, he developed
recurrent septic complications, and was referred
for further management.
FIGURE 1A Sagittal view from an MRCP sequence demonstrate a complex cystic lesion in communication with the common
bile duct (black arrow) arising from caudate lobe inferior to the left lateral segment (Segment III).BILIARY OBSTRUCTION DUE TO MUCOBILIA 347
At the time of referral, he was jaundiced, pru-
ritic, and febrile (38.7 C). Laboratory evaluation
revealed a white blood cell count of 14.7cm3, a
hemoglobin of 9.4mg/dl, normal serum elec-
trolytes, an AST of 86mg/dl, an ALT of 121
mg/dl, an alkaline phosphatase of 686mg/dl
and a bilirubin of 8.7mg/dl. Repeat hepatitis
serologies and alpha-fetoprotein (AFP) and
carcinoembryonic antigen (CEA) serum levels
were normal. On physical examination, the pa-
tient was deeply jaundiced with skin changes
consistent with chronic urticaria. Bitemporal
wasting and loss of skin turgor suggested exces-
sive weight loss and dehydration. The sclera
were icteric. Cardiac and pulmonary exams were
unremarkable. The abdominal exam revealed a
well healed right subcostal incision. No hepato-
splenomegaly, masses, or hernias were palpable.
A duplex ultrasound (DUS), magnetic resonance
cholangiopancreatography (MRCP), and hepa-
tic arteriogram were obtained. The DUS revealed
an 8-cm multiloculated cystic mass with inter-
nal septations located within the caudate lobe of
the liver. Intrahepatic biliary dilatation was pre-
sent in both the right and left lobes. The MRCP
confirmed the presence of a complex cystic
caudate lobe mass that appeared to communicate
with the caudate duct. (Figs. 1A, B, and C). The
arteriogram revealed normal celiac and superior
mesenteric arterial anatomy.
At operation, dense adhesions were encoun-
tered, and there was early evidence of left lobe
atrophy and portal hypertension. A 10 x 12-cm
cystic lesion of the caudate lobe extending medi-
ally into the base of segment IV, and superi-
orly into segment II was identified. A left
hepatectomy with caudate lobectomy, and cho-
lecystectomy was performed. Following transec-
tion of the left hepatic duct, mucus was
observed to extrude from the right hepatic duct
FIGURE 1B Sagittal view from an MRCP sequence demonstrate a large cystic lesion within the caudate lobe (black arrow),
displacing the portal structures and causing intrahepatic biliary dilatation (white arrow).348 R.S. CHAMBERLAIN AND L. H. BLUMGART
FIGURE 1C T2-weighted MRI image demonstrating the origin of a complex cystic lesion within the caudate lobe. The inferior
vena cava (white arrow) is markedly compressed, and the left portal vein displaced to the right (black arrow). Left-sided biliary
dilation is very apparent with a prominent and dilated segment III bile duct.
and common bile duct under intense pressure. A
pediatric Yankauer suction catheter was used to
lavage the biliary tree and remove inspissated
mucus in order to restore biliary flow. The pa-
tient’s post-operative course was prolonged and
complicated by a recurrent intra-abdominal bi-
loma and upper gastrointestinal hemorrhage. He
was discharged on the 39th post-operative day.
At 10 months follow-up he has regained 30
pounds, and returned to an active work and
social life. There was no evidence of recurrent
tumor.
Pathological review of the specimen revealed
a 9 x 14 x 2-cm cystic lesion arising from the
caudate duct with a single 6-mm focus of pa-
pillary cystadenocarcinoma with oncolytic fea-
tures. There was massive cystic dilatation of the
caudate duct associated with this neoplastic
process. No vascular, perineural, liver or extra-
ductal tissue invasion was identified. The resec-
tion margins were clear of tumor. The remainder
of the liver showed evidence of chronic large duct
biliary obstruction. All celiac and periportal
lymph nodes were negative for tumor.
DISCUSSION
Jaundice is a common presentation for many
hepatobiliary and pancreatic malignancies and
occurs most commonly as a result of compres-
sion or blockage of the extrahepatic bile duct
by tumor. Jaundice may also occur as a result of
direct portal venous invasion and subsequent
hepatic atrophy, tumor emboli into the portal
vein, intraductal tumor embolus, extrahepatic
bile duct metastases, extrinsic compression of the
extrahepatic bile duct by nodal metastases, or
mucobilia with obstruction of the bile duct by
inspissated mucus. Mucobilia has been reportedBILIARY OBSTRUCTION DUE TO MUCOBILIA 349
in association with both benign and malignant
neoplasms of the pancreas, liver, and bile duct
[1-4]. Benign conditions include biliary mucino-
sis (characterized by mucus metaplasia of the
entire extrahepatic biliary tree), biliary papillo-
matosis (a benign polypoid neoplasm which may
involve any part of the biliary tract or gallblad-
der,) and cystadenomas of either the pancreas or
bile duct [3,4]. Of note, even in the setting of
biliary mucinosis or papillomatosis in which
secretions may be voluminous, biliary ob-
struction and jaundice are rare events. Malignant
conditions that may result in mucobilia include
MPCC, and cystadenocarcinomas of the pan-
creas, liver or biliary tree [5-9]. Twenty cases of
mucobilia in association with a MPCC have been
reported to date [5-10]. The extent of mucin
production in association with MPCC is highly
variable, and mucin is generally retained within
the tumor cells. Less than 50% of all cases of
MPCC associated mucobilia have resulted in
jaundice [5- 7].
Biliary cystadenomas (BC) and biliary cysta-
denocarcinomas (BCCA), represent a distinct
group of mucin-producing intrahepatic biliary
neoplasms that may result in mucobilia and
biliary obstruction [2]. Both BC and BCCA are
rare cystic tumors constituting less than 5% of
all intrahepatic cystic neoplasms [1,11]. Fifty
percent of these tumors arise in the right lobe,
29% in the left lobe, and 16% are bilobar [11].
They can arise from either intrahepatic or less
commonly extrahepatic bile ducts and occur
predominantly in middle-aged women (62%,
mean age 56.2 years) [11]. BC and BCCA re-
semble similar lesions, which may develop
within the pancreas and are classified as either
multilocular (as in the current case) or papillary,
with the former being more common. The
clinical presentation is generally mild with right
sided abdominal pain or discomfort (57%) being
the most common finding followed by an ab-
dominal mass (30%), and elevated liver function
tests (26%) [11]. Symptoms such as bone pain,
ascites or jaundice are rare and usually indica-
tive of advanced disease [11, 12]. Serologic
tumor markers such alphafetoprotein (AFP), car-
cinoembryonic antigen (CEA), and CA 19-9 are
generally not helpful, and are elevated in 8%,
14%, and 36% of patients respectively [11]. Ad-
equate pre-operative assessment of these intra-
hepatic tumors can be accomplished with a
variety of imaging modalities including ultra-
sound, CT, magnetic resonance imaging (MRI),
endoscopic retrograde cholangiopancreatogra-
phy (ERCP) or percutaneous transhepatic cho-
langiography (PTC). The sensitivity of these
studies to identify BC and BCCA is reported as
100%; the specificity is unknown [11,13]. The
typical appearance on either ultrasound or axial
imaging (CT or MRI) is a hypodense cystic
lesion with internal septa or papillary projec-
tions. While not pathognomonic, these findings
should suggest the diagnosis of a BC or BCCA.
Cholangiocarcinoma more typically present with
a solid mass and proximal dilatation, as op-
posed to BC or BCCA that typically arise from a
single duct or multiple ducts with surrounding
ectasia and without evidence of proximal ob-
struction. Diagnosing mucobilia in the absence
of endoscopic cholangiography or operative eva-
luation is difficult, and although some authors
have described a characteristic diffuse ground
glass appearance to the dilatation of the intra-
hepatic bile duct, this is not widely accepted [13].
Biliary ductal ectasia limited to one or several
adjacent ducts without prominent diffuse ductal
dilatation is the characteristic cholangiographic
appearance of both BC and BCCA. ERCP or PTC
may identify a direct communication between
the cyst and individual intrahepatic ducts which
can be important in presurgical planning.
Hyperechoic spots seen within these dilated
ducts, either on ultrasound or axial imaging,
may represent mucin but is not diagnostic [13].
Filling defects seen within dilated hepatic ducts
may represent a number of conditions including
air bubbles, blood clots, tumor nodules from a
papillary neoplasm, intrahepatic stones or mu-
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distinguishing between these entities but may
not be diagnostic. Precise differentiation be-
tween these entities usually requires histopatho-
logic analysis. In the current case, magnetic
resonance cholangiopancreatography (MRCP)
was utilized to image this lesion in both the
axial and sagittal plane. MRCP is capable of not
only defining the anatomic location of the
tumors within the liver but may also demon-
strate a communication between the tumor and
the intrahepatic biliary tree without the need for
invasive procedures. Fine needle aspiration
(FNA), which has been a useful adjunct in the
pre-operative evaluation of many hepatobiliary
malignancies, is generally contraindicated when
a BC or BCCA are suspected. FNA risks not only
introducing bacteria into a sterile cyst cavity, but
more importantly may result in dissemination
of tumor cells.
Ishak et al., reported fourteen cases of BCCA
and identified a single case of mucobilia due to
either a BC or BCCA [14]. Lauffer et al., reviewed
113 cases of BCCA reported in the literature up
until 1998 and reported on sixteen patients pre-
senting with jaundice [11]. A precise cause for
the jaundice in these cases was not provided,
however the authors did state that it was due to
either tumor compression of the extrahepatic
bile duct, parenchymal displacement by tumor,
or rarely mucus hypersecretion. Kokubo et al.,
reported on six patients with mucobilia resulting
from a mucin-hypersecreting intrahepatic biliary
neoplasm [7]. Four of the six cases were BCCA,
one was a MPCC, and in one case the pathology
was indeterminate. In three cases of BCCA,
jaundice was the presenting complaint.
Macroscopically, BCCA are typically multi-
loculated (84%) cysts lined by papillary adeno-
carcinoma [1,11]. Histologically, BCCA differ
from BC, in that they possess a cellular pleo-
morphism and anaplasia with infiltration of the
underlying fibrostroma. The malignant epithe-
lium is typically multi-layered with numerous
papillary projections, with breaks or erosion in
the basement membrane. Benign columnar
epithelium is observed in nearly all cases (91%),
and was present in the current case [1, 11]. The
presence of benign cystic epithelium adjacent to
malignant epithelium supports most patholo-
gists’ belief thatBCCA arise within BC. BCCA are
generally large (mean 12.4 cm), with a reported
range of 1.2 to 30cm [11]. Invasion into blood
vessels, adjacent liver or nearby organs occurs in
roughly half of all cases (52%), with distant
metastases (20%), and lymphatic spread (13%)
occurring infrequently [1, 11]. Wolf et al., has
recently described an oncocytic and non-oncocy-
tic variant of BCCA that may have prognostic
implications [15]. Oncocytic epithelial cells, or
oncocytes, are cells with abundant, bright eosi-
nophilic and granular cytoplasm and exuberant
numbers of mitochondria. These cells have been
described in malignancies of the pancreas,
salivary glands, ovary, and breast, and in these
cases the non-oncocytic tumor population deter-
mines the potential for tumor progression. In
the current case, the invasive component of the
tumor was 6-mm in size, and was noted to re-
semble those ofan intraductal oncocytic papillary
carcinoma of the pancreas that is usually asso-
ciated with a favorable prognosis [16].
Similar to other causes of malignant biliary
obstruction, surgical resection is standard ther-
apy for BCCA (with or without mucobilia).
Patients otherwise fit for operation and without
evidence of lymph node or distant metastases
should be explored. It is our practice to perform
a diagnostic laparoscopy on all patients with a
suspected biliary malignancy to exclude the
presence of obvious extrahepatic disease. If the
location of the offending lesion has not been
clearly delineated pre-operatively, significant ef-
fort should be aimed at identifying the location
of the lesion to ensure it is included within
the resected specimen. Excessive mucorrhea may
limit the ability of intraoperative ultrasound or
bi-manual palpation of the liver to provide
helpful information in identifying tumor loca-
tion. In these instances, choledochoscopy may
be useful in not only providing direct tumorBILIARY OBSTRUCTION DUE TO MUCOBILIA 351
visualization, but also allowing for biopsy and
histologic diagnosis. However, given the diffi-
culty in differentiating between reactive atypia
and a malignant neoplasm on frozensection, and
the potential for malignant transformation of
many biliary neoplasms, a benign intraoperative
histologic interpretation should not discourage
an attempt at complete surgical resection with
negative margins. Since mucus may also result in
obstruction of the bile duct on the contralateral
side of the offending lesion, intraoperative lavage
of the entire biliary tree to remove offending
mucus plugs is an important part of the pro-
cedure. Free flow of bile from the contralateral
lobe of the liver should be restored and is
vitally important when pre-operative biliary in-
tubation has occurred, since bactobilia in these
patients approaches 100%. The overall 5-year
survival for patients with a BCCA undergoing
surgical resection is 65-71%. If a complete
surgical resection with negative histologic mar-
gins is achieved, a two- and five-year survival
rate of 100%, and a recurrence rate of 13% has
been reported [1,11].
CONCLUSIONS
Mucobilia is a rare cause of malignant biliary
obstruction associated with a number of benign
and malignant mucin-producing pancreatic and
biliary neoplasms. Although radiologic imaging
of the biliary tree cannot provide a definitive
diagnosis of obstruction due to mucin, intrahe-
patic biliary ductal dilatation in association with
jaundice, with or without the presence of a solid
tumor within the biliary tree, should prompt
one to consider this diagnosis. The presence or
absence of mucobilia does not change the algo-
rithm for dealing with patients with malignant
biliary tract obstruction due to any cause; sur-
gery remains the mainstay of therapy. Complete
resection with negative histologic margins may
be curative in nearly all cases of BCCA.
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